chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient parent (mom) reported he (12 y/o male patient) was feeling dizziness after vaccination (vaccinated at 4:25 pm reported dizziness at 4:38 pm). Patient also reported a little nausea and headache. Emergency System was called and they arrived at 5;10 pm. They check BP, Sugar and everything was within normal levels BP 110/70 and BS 99. Mom decided not to have him go to the hospital because symptoms improve
Tingling on tongue; swelling of lymph nodes on neck and arm of injection; swelling of lymph nodes on neck and arm of injection; Muscles and joint hurts; Muscles and joint hurts; Headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA ORAL (Tingling on tongue), SWELLING (swelling of lymph nodes on neck and arm of injection), PERIPHERAL SWELLING (swelling of lymph nodes on neck and arm of injection), MYALGIA (Muscles and joint hurts) and ARTHRALGIA (Muscles and joint hurts) in a 79-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 046A42A and 012M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included COLECALCIFEROL, MENAQUINONE-7, PHYTOMENADIONE, RETINOL PALMITATE, TOCOPHEROL, TOCOTRIENOLS NOS (VITAMIN D COMPLEX) and ACETAMINOPHEN for an unknown indication.   On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 13-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 13-Mar-2021, the patient experienced PARAESTHESIA ORAL (Tingling on tongue), SWELLING (swelling of lymph nodes on neck and arm of injection), PERIPHERAL SWELLING (swelling of lymph nodes on neck and arm of injection), MYALGIA (Muscles and joint hurts), ARTHRALGIA (Muscles and joint hurts) and HEADACHE (Headache). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) at a dose of 50 mg. At the time of the report, PARAESTHESIA ORAL (Tingling on tongue), SWELLING (swelling of lymph nodes on neck and arm of injection) and PERIPHERAL SWELLING (swelling of lymph nodes on neck and arm of injection) had resolved and MYALGIA (Muscles and joint hurts), ARTHRALGIA (Muscles and joint hurts) and HEADACHE (Headache) outcome was unknown.            Other relevant concomitant medications included berry tablets.
5 x 6 cm erythematous, macular area on posterior upper arm around injection site. 1 x 2 cm bluish area in center, nontender. Focal area of tenderness posterior to injection site.
Allergic to it as well; This spontaneous case from was received on 07-Jan-2021 from pharmacist via Med Communications (reference number: SEQW21-00095) and concerned a female patient of an unreported age.  The patient's past vaccination included Fluvirin ((inactivated influenza virus surface antigen (subunit), egg-derived, influenza vaccine) on 15-Sep-2010 after which the patient follow up skin test, which reacted to it and the patient was allergic to the vaccine. The patient's concomitant medications and medical history were not reported.  On an unspecified date in 2011, the patient was vaccinated with Fluvirin (dose, route of administration, anatomical location: not reported) for influenza prophylaxis. The batch number reported was 11035PA and expiry date was Apr-2020.  On an unspecified date in 2011, unknown amount of time after receiving Fluvirin, the patient performed a second skin test, which resulted positive. She was allergic to it as well. The patient saw allergist.   The outcome of the event was not reported.  The reporter assessed the event to be releted to Fluvirin. The reporter stated that the patient was allergic to it as well.  The case was assessed as non-serious.  This case is linked to 202100270 due the same patient.  Company Comment: The event is considered as related to Fluvirin.; Reporter's Comments: The reporter stated that the patient was allergic to it as well.; Sender's Comments: The event is considered as related to Fluvirin.
Patient is complaining of arm pain continuing long after she has received her vaccination. She stated its a throbbing pain that comes and goes but is worse at night.
Information has been received from a pharmacist, and  via a company representative, concerning a patient (age and gender not reported) with an unknown medical history, who "within the last six weeks" was vaccinated (route unknown) with a 0.5 ml dose of pneumococcal 23v polysaccharide vaccine (Lot# unknown).  It was reported that the patient experienced a severe local reaction just after receiving the shot.  The pharmacist reported that "within the last six weeks" the patient developed a cellulitis reaction.  It was reported that the patient may have received the vaccine from a multi dose vial or from a single dose vial.  The outcome was not reported.  No product quality complaint was involved.  Additional information has been requested.
Nausea and vomiting, headaches,for 6 days. Followed by an Emergency Room treatment for migraines MRI revealed a 2.5 cm pituitary gland nodule
Information has been received from a consumer concerning an approximately 5 - 12 year old child who in approximately 1996 - 2003 was vaccinated with a dose of varicella virus vaccine live. Subsequently, the patient experienced a mild case of chicken pox. Unspecified medical attention was sought. The patient subsequently recovered. There was no product quality complaint involved.
Approx 3 days after receiving zoster vaccine pt developed erythematous plaque post. neck crossing midline with burning pain persisting til at least 11/19/12.
By 1:30 am on 2/4/2021; patient was shaking uncontrollably.  This continued about 1 1/2 hrs. then he could not get out of bed to go to the bathroom; thus wetting himself multiple times during the night; Patient was restless for about 5 hrs. but still could not get up even with me (his spouse) trying to help.  He also could not understand how to help move his body to keep from falling out of bed (never fell out but I could not get his entire body on the bed until our daughter arrived around 9:30 am.  It took our grandson who is 6'5" tall & 275 lbs. to help get patient up and walked him into our sunroon.  throughout the day, patient could not stand without help & continued to urinate on himself.  He could, however, feed himself breakfast & lunch.  At 7:30 pm grandson and daughter had to walk patient into bedroom.  patient could not walk without us telling him how and pushing his feet forward.  It took both grandson and daughter to pull him onto the bed as he collapsed when he got to the bed.  Patient slept until approximately midnight. at that time our daughter helped him to the bathroom and helped to change his underwear and tshirt which was wet from having a fever.  Afterward, patient was able to go to the bathroom by himself but was very tired.  He was able to walk outside with the help of a cane on 2/5/21 2 pm.  On 2/6/21, patient complained of his back hurting and itching.  We discovered he had shingles!  Not a full body rash but shingles on his left side around his waist.
arm itchy; swelling in hands and arm; arm hurts; This is a spontaneous report from a contactable consumer or other non hcp (patient).     A 24-years-old female patient received first dose of bnt162b2 (BNT162B2, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in Arm Right on 24Feb2021 14:00 as DOSE 1, SINGLE for covid-19 immunisation (age at vaccination 24 years). Medical history was none. Concomitant medication included ascorbic acid, betacarotene, biotin, calcium, chromium, colecalciferol, copper, eleutherococcus senticosus root, folic acid, iodine, iron, magnesium, manganese, nicotinic acid, pantothenic acid, potassium, pyridoxine hydrochloride, riboflavin, selenium, spirulina spp., vitamin b1 nos, vitamin b12 nos, vitamin e nos, zinc (WOMEN'S MULTI [ASCORBIC ACID;BETACAROTENE;BIOTIN;CALCIUM;CHROMIUM;COLECALCIFEROL;COPPER;ELEUTHEROCOCCUS SENTICOSUS ROOT;FOLIC ACID;IODINE;IRON;MAGNESIUM;MANGANESE;NICOTINIC ACID;PANTOTHENIC ACID;POTASSIUM;PYRIDOXINE HYDROCHLORIDE;RIBOFLAVIN;SELENIUM;) taken for an unspecified indication from an unspecified start date and ongoing; biotin (BIOTIN) taken for an unspecified indication from an unspecified start date and ongoing. The patient experienced swelling in hands and arm, arm hurts on 25Feb2021, arm itchy on an unspecified date. Caller stated, she had swelling in hands and arm. Also when she laid on her arm it hurt and she was itchy. Therapeutic measures taken as a result of events included treatment with Tylenol and Advil. The events resulted in physician office visit. The outcome of the events was recovering.  No follow-up attempts are possible. No further information is expected.
Myalgia, malaise, headache, burning pain in right axilla for 3 days. Then, lymphadenopathy in right axilla
Information regarding influenza virus vaccine was received from a consumer, regarding her 79 year old mother, who experienced flu-like symptoms following receipt of the influenza virus vaccine when she was 77 years of age. No additional info was available at the time of this report.
I also feel the fatigue in the past few months; finger joint and left arm became numb and swollen.; finger joint and left arm became numb and swollen.; The rib and back also aches; The rib and back also aches; The thrombus level elevated to 4.6.  After taking antibiotics, it dropped to 0.6; the left  wrist joint and left face joint became swollen; This is a spontaneous report from a contactable consumer, the patient:   A 69-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown and expiry date was not provided) via an unspecified route of administration in the left arm on 17Mar2021 at 12:30 (at the age of 69-years-old) as DOSE 2, SINGLE for COVID-19 immunisation. Medical history included Blood pressure high from an unknown date and Unknown if ongoing. Concomitant medications were not reported. The patient did not have known allergies. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The events resulted in a doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had been tested for COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation; Solution for Injection; Lot Number: Unknown and expiry date was Not provided) via an unspecified route of administration in the left arm on 24Feb2021 at 13:15 (at the age of 69-years-old) as a DOSE 1, SINGLE for COVID-19 immunisation. On 17Mar2021 at 16:30, after four hours of the 2nd dose of vaccination, the patient experienced the left wrist joint and left face joint became swollen. On 07Apr2021, the patient's thrombus level elevated to 4.6 and after taking antibiotics, it dropped to 0.6, on 09Apr2021, the patient's finger joint and left arm became numb and swollen which spread to the right side and even the rib and back also had ached, the patient felt fatigued in the past few months. It was reported that her doctor prescribed Lyrica in May but the patient stopped taking it in July since it did not alleviate the pain. The events were assessed as Non serious. Therapeutic measures were taken as a result of swollen joints, thrombin increase, numbness, ache and fatigue included treatment with unspecified medications and pregabalin (LYRICA). The patient underwent lab tests and procedures which included Thrombus level on 07Apr2021 as 4.6 and 0.6 on 07Apr2021, on 03Apr2021, the patient underwent a SARS-CoV-2 test (PCR) and the result was negative. The clinical outcome of the events thrombus level elevated to 4.6 was resolved on 09Apr2021 while that of the events the left wrist joint and left face joint became swollen, finger joint and left arm became numb and swollen, rib and back also aches and fatigue was not resolved at the time of this report.  The lot number for BNT162b2 was not provided and will be requested during follow up.
Chest "fullness" going up to neck and head.  BP 141/82 Pulse 83 O2 98% R 18  Assessed by APN at time of incident. Pt declined ER. Will follow up with PCP
Patient tested positive for COVID-19; A spontaneous report was received from a consumer concerning a 59-years-old female patient who received Moderna's COVID-19 vaccine (mRNA-1273) and experienced event, tested positive for covid-19.  The patient's medical history was not provided. No relevant concomitant medications were reported.  On 25 Jan 2021, prior to the onset of the events the patient received first of two planned doses of mRNA-1273 (lot/batch: D04M20A) intramuscularly in left upper arm for prophylaxis of COVID-19 infection.  On 20 Feb 2021, the patient experienced the event, patient tested positive for covid-19.She reported that her husband tested positive 01FEB2021, and son tested positive 05FEB2021 but  tested negative 10FEB2021,02FEB2021,05FEB2021 respectively. Treatment details included not provided.  Action taken with mRNA-1273 in response to the events was not reported.   The outcome of event , patient tested positive for covid-19 was unknown.
This spontaneous report as received from a pharmacist via a company representative refers to a female patient of unknown age. No information on medical history and concomitant information was provided. On an unknown date the patient was vaccinated with one standard dose of ZOSTAVAX for prevention of shingles (dose, dose number and route of administration unknown). On an unknown date the patient became very dizzy, but could walk on her own. Additional symptoms were an overall extreme body warmth and "tingly sensation". The administrating Pharmacist "called 911". The outcome of became very dizzy, tingling sensation and overall extreme body warmth is unknown. Additional information is not expected.
COVID breakthrough first dose 3/12/2121 EN6199, second 4/2/2021 ER 8737, booster 11/29/2021 330308D.  SNF transfer screen 6/2/2022 positive. 91 year old female with a Past Medical History of Occlusion and Stenosis of the Carotid Artery, Hypothyroidism, Panic Disorder, E. Coli, Hypertension, UTI, Hyperlipidemia, OSA, Chest Pain, Peripheral Vascular Disease, Muscle Spasm, Osteoarthritis, Urgency of Urination, Achilles Bursitis, Headache, Alopecia, Abnormal Weight Gain, Lumbago, and Fatigue.  She is Admitted to Medical Med/Tele for  Altered Mental Status, UTI, S/P Fall, Small Hematoma, Right Partial Scalp Swelling, Dizziness, Hypertension, Hyperlipidemia, OSA, nd Hypothyroidism. Patient does complain of increased weak
fever, chills, body aches, diarrhea, nausea Narrative: Took OTC NSAID
Information has been received from a physician concerning a 31 year old female who on 12/12/03 was vaccinated SC with a first dose of rubella virus vaccine live (lot number not available). In approximately 12/03, the patient's titer came back negative. At the end of February 2004, the patient was vaccinated SC with a second dose of rubella virus vaccine live (lot number not available), and subsequently, in approximately February 2004, the patient still showed no immunity. The physician reported that immunity to rubella is a requirement for in vitro fertilization to take place. The outcome was unknown. Additional information has been requested. Follow up 03/03/05: Patient date of birth and lot number for vaccine 1 not provided. Adverse event onset was approximately 2003.
I gave pt vaccine on the left thigh and when I was done I went to enter in the system and realize I gave her the wrong vaccine immediately let the provider know of what occur. No symptoms and no signs of threat to patient.
I don?t if this is related to receiving the Covid vaccine or not but I thought I would report this just in case. About one month after receiving the second Covid vaccine as listed above, I developed shingles on the left side of my neck and face.  Aching developed on 3/3/21 and the rash first appeared on 3/6/21.
Patient developed swelling, itching and pain in right arm below deltoid. She developed blisters which broke very quickly and oozed a little fluid; also felt achy. This started within 2 days of receiving vaccine. She was seen by Dr on 2/14/2012 and the area was still red, raised and indurated with a small amount of edema.
10/14 Inflammation, redness, pain to the elbow. 10/15 same symptoms no bruising.
Site: Itching at Injection Site-Medium, Site: Redness at Injection Site-Medium, Additional Details: Symptoms of red arm, warm to touch on day after shot. Recommended continue to take support medications. can be reaction from vaccine. watch, call if seemed to get worse.
Restlessness and jerking awake when trying to sleep, nerve pain in arms, organ pain particularly kidneys.  It lasted about 24 hours from when it started. I?ve had this type of systemic reaction before to sulfa and ondansetron. I don?t know what ingredient in the shot I reacted too.
2 hours after vaccine administration, he developed respiratory depression (respiratory rate 6/min), hypothermia (33.2 degrees C) and rhythmic head movements consistent with seizure activity requiring intravenous ATIVAN. After supportive treatment with oxygen therapy and patient warming, he returned to baseline neurologic function after about 15 hours from the time of vaccine administration.
Red, swollen, warm, itchy/burning sensation, at sight of INJ. Abnormal large 6 inches.
So later that evening around 9:30pm I started with Chills, and a low grade fever lots of body ache and head ache, to the point I did not get much sleep the night of. It lasted the whole next day. But later in the evening of the next day I think to me the most concerning side effect was I started getting some chest pain as if I pulled a muscle around my chest or what not. And it has continued into the next day as well which is now 2 days after second dose of vaccine.
Aches in back and joints and fatigue beginning about 12 hours after shot and lasting until 24-32 hours after shot. Some chills beginning about 18 hours after shot and lasting until 24 hours after shot.
Very Emotional and headache . Lasted about an hour.  Throat felt like i was about to cry .
HSV1 outbreak 2 days after receiving Covid booster shot. Diagnosed/initial outbreak in 08/2021 with no recurrence until receipt of the booster shot
Initial report received FLUZONE ID (Lot # UT4723BA and expiration date unknown) intradermal on deltoid in-between date and 31-Oct-2013. Within 24 to 48 hours of vaccination, the patients experienced increased swelling and heat on deltoid which were quarter sized to softball size. One allergic reactions and hives. At the time of the report the patients were recovering from the reported events. Documents held by sender: none.
I got swollen lymnodes on my collar done, they went down; This spontaneous case was reported by a consumer and describes the occurrence of LYMPHADENOPATHY (I got swollen lymnodes on my collar done, they went down) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. Unknown) for COVID-19 vaccination.     No Medical History information was reported.    On 30-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, the patient experienced LYMPHADENOPATHY (I got swollen lymnodes on my collar done, they went down). At the time of the report, LYMPHADENOPATHY (I got swollen lymnodes on my collar done, they went down) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant therapy information was provided by the reporter.  No treatment information was provided by the reporter.   This case was linked to MOD-2021-224993 (Patient Link).
The spontaneous report was received from a pharmacist regarding three unspecified children of 17 or 18 years of age. There was no information about concurrent condition and historical medication. ON an unknown date, the children of 17 or 18 years of age were vaccinated with ZOSTAVAX vial 19400 PFU (drug administered to patient of inappropriate age instead ov VARIVAX) (wrong drug administered). No concomitant medication was reported. No adverse event was reported. No product quality complaint PQC was involved. Reporter stated that she doe not know whether or not medication confusion was involved in this error, since she was not the person who prepared the doses for the three children. The outcome of children of 17 or 18 years of age was vaccinated with ZOSTAVAX instead of (Oka/Merck) VARIVAX was unknown. Additional information has been requested.
Received Phizer COVID 19 vaccine on Tuedsay, January 5, 2021. Friday am did not feel well, Congestion, HA and CP. Friday evening shaking chills and fever with extreme fatigue. GI symptoms and congestion Saturday. Feeling better by Saturday evening.
After administering the first dose,  patient became itchy and blotchy all over body.  At 11:04am gave patient Benadryl 50mg.  By 11:12am redness was going away.
Chills, achy, fever up to 102, migraine/headache, upset stomach (ate very little), nauseas Mostly slept, took 3 ibuprofen after 9 hours and again 4 hours later, fever, upset stomach, and aches gone after 12 hours, chills and continued off and on  overnight Original symptoms gone a little over 24 hours later.  Arm pain has returned and is radiating up through collar bone.
Irregular periods, PCOS, uterus rejecting Paragard IUD that had been in place for 1.5 yrs, regrowth of a common wart on wrist that was removed 24 years prior, skin changes on chest and upper arms. Work up and treatments include but not limited to: Various rounds of lab testing, wart removal medications/visits/procedures, hospital admission r/t IUD rejection, CT scans, ultrasounds, IUD removal
PATIENT RECEIVED A PFIZER VACCINE THAT WAS NOT STORED ACCORDING TO THE MANUFACTURERS RECOMMENDATIONS (2-3 DAYS PAST THE EXPIRATION DATE).   ALTHOUGH RECOMMENDED TO REPEAT THE VACCINE, PATIENT CHOSE NOT TO DUE SO AND JUST DO THE SECOND DOSE IN THE FUTURE AT THE APPOINTED TIME.  PATIENT DID EXPERIENCE A NORMAL IMMUNE RESPONSE TO THE VACCINE.
Patient had fevers/chills/sweats for a couple days post, had felt improved but then woke up with diaphoresis, then went back to sleep, then awoke with left sided chest pain going to his left shoulder. Denies a hx of chest pain. Denies a family hx of early CAD
Pt said her arm was inflamed & swollen below the vaccination site up to her elbow, pain, redness, hot to the touch.
This case was reported by a consumer via call center representative and described the occurrence of tingling in a female patient who received SHINGRIX for prophylaxis. On 6th February 2019, the patient received the 2nd dose of SHINGRIX. On 12th February 2019, 6 days after receiving SHINGRIX, the patient experienced tingling, rash, welts and pruritus. On an unknown date, the outcome of the tingling, rash, welts and pruritus were unknown. It was unknown if the reporter considered the tingling, rash, welts and pruritus to be related to SHINGRIX. Additional details were provided as follows: The patient experienced some side effects including tingling neck, bumps, spots or welts on her upper arms and back and tremendous itching. This case linked with US2019030628, reported by same reporter for the different patient (husband's case).
11/16/19 AM had warmth and slight swelling to injection site. Temp 99.6F c/o chills 11/17 increase in redness to 4'2 x 5" 11/18 injection site very warm left message for PCP 11/20 Appt to see PCP dx cellulitis Treated with antibiotic Keflex 11/21 decrease warmth 1/30/20 Update patient completely recovered and rec'd dose #2 without any complications.